All systems operational
For Researchers For Publishers Login Register
Home Publications Annals of Saudi Medicine
Q2 2025 Vol. 20 · No. 3 · pp. 555-574

errata

10.5144/0256-4947.2025.445 1,770 Views 0 Citations
0
Citations
1,770
Views
Vol. 20, No.3
Volume / Issue
555-574
Pages
Abstract not available for this publication.
Cite this Article (APA)
(2025). errata. Annals of Saudi Medicine, 20(3), 555-574. https://doi.org/10.5144/0256-4947.2025.445
Related Papers
Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diab…
Moaz Safwan; Mariam Safwan Bourgleh; Shahad Abdullah Alotaibi; Eman Alotaibi; Ab · 2025
11
cites
1,080
Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia
Muhammad Imran Butt; Khalid Mania Alkhalifah; Muhammad Riazuddin; Saud Mohammed · 2024
9
cites
1,708
Prevalence of hyponatremia among medically hospitalized patients and associated outcomes: a retrospe…
Intisar Hamood Al Yaqoubi; Juhaina Salim Al-Maqbali; Afnan Ahmed Al Farsi; Rayan · 2024
8
cites
1,981
Estimating the prevalence of select non-communicable diseases in Saudi Arabia using a population-bas…
Suliman Alghnam; Mohammad Bosaeed; Abdulrahman Aljouie; Saeed Mastour Alshahrani · 2024
5
cites
1,930
Access
View Full Text via DOI
Published in
ISSN 0256-4947
Quartile Q2
AMS Score 83
Field Medicine & Health Sciences
Publisher King Faisal Specialist Hospital
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Publication Details
Year 2025
Volume 20
Issue 3
Pages 555-574
Language English
Added 23 Jun 2026